Novartis Investigative Site

Santa Coloma de Gramanet, Catalonia 08923

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Chronic Plaque Psoriasis, Moderate to Severe Plaque-type Psoriasis, Type 2 Diabetes Mellitus

Studies at this site

• Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis — Completed
• Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early